Cover Image
Market Research Report
Product code 
1001467

Middle East and Africa Cell Line Development Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type, Product, Application

Published: | The Insight Partners | 101 Pages | Delivery time: 1-2 business days

Price

Back to Top
Middle East and Africa Cell Line Development Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type, Product, Application
Published: March 17, 2021
The Insight Partners
Content info: 101 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The Middle East and Africa cell line development market is expected to reach US$ 626.07million in 2027 from US$ 247.84million in 2019. The market is estimated to grow at a CAGR of 12.4% from 2020-2027.

The growth of this market is attributed to the increasing focus on the research and development activities related to cell line development and a high prevalence of cancer in the region. However, several issues related to the cell line development are hindering the market growth.

Significant growth of the cell line development market in the Middle East and Africa is mainly attributed to increased healthcare expenditure as well as initiatives by the governments of various countries to boost research and development activities related to life sciences. The availability of technologically advanced devices and research facilities, and rising number of conferences on synthetic biology and genetic engineering are other factors contributing to the growth of the market in this region. With the emphasis on industrialization, the UAE is encouraging start-ups and research enthusiasts in the country by providing them with potential platforms, research facilities, and other conveniences to develop cell line development innovations. DUBIIOTECH-i.e., Dubai Biotechnology and Research Park-is a science and business park dedicated to the biotechnology and biopharmaceutical industry modeled on a free-zone concept. The biotech park assists government-funded research and development projects through world-class infrastructure that includes services and commodities for R&D labs, research and academic institutes, manufacturing companies, and start-ups, along with the organizations from supporting and convergent industries.

Moreover, with the increasing number of research projects, institutes such as King Abdullah University of Science and Technology are contributing significantly to research and technology developments in the region. Synthetic biology, next-generation sequencing, and personalized medicines are among the emerging fields in the region. Most individual researchers and start-up companies are now focusing on developing innovative products through these technologies in Saudi Arabia.

COVID-19 has dramatically impacted clinical trials due to site closures, stay-at-home orders, and supply chain issues, among other barriers. The pandemic has amplified a few of the difficulties that have been a part of clinical trials in low-middle-income countries since long. A few of the lower-middle-income countries have issued guidance or directives pertaining to clinical research during the pandemic, which are similar to those issued by the FDA and the European Medicines Agency. However, as most countries have not issued specific COVID-19 guidance for clinical trials, there are uncertainties around the study protocol, which are leading to often delays in regulatory approvals in these countries, thereby limiting the cell lone development market growth.

Based on type, the Middle East and Africa cell line development market is segmented into a primary cell lines, hybridomas, continuous cell lines, and recombinant cell lines. The recombinant cell lines segment held the largest market share in 2019, whereas the hybridomas segment is anticipated to register the highest CAGR in the market during the forecast period.

The Middle East and Africa cell line development market, by product, is segmented into equipment, and media & reagent. The media & reagent segment held the largest share of the market in 2019, and it is anticipated to register the highest CAGR in the market from 2020 to 2027.

Based on application, the Middle East and Africa cell line development market is segmented into drug discovery, bioproduction, and tissue engineering. The bioproduction segment held the largest market share in 2019. However, the drug discovery segment is anticipated to register the highest CAGR in the market during 2020-2027.

A few of the primary and secondary sources referred to while preparing the report on the Middle East and Africa cell line development market are the Cancer Association of South Africa (CANSA) and Dubai Health Authority (DHA).

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East and Africa cell line development market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa cell line development market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth, offering developed and emerging markets.

Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table of Contents
Product Code: TIPRE00020319

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Cell line development Market - By Type
    • 1.3.2 Cell line development Market - By Product
    • 1.3.3 Cell line development Market - By Application
    • 1.3.4 Middle East and Africa Cell line development Market - By Country

2. Middle East and Africa Cell Line Development Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Middle East and Africa Cell Line Development Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Cell Line Development Market- Middle East and Africa PEST Analysis
  • 4.3 Expert Opinion

5. Middle East and Africa Cell Line Development Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Focus on the Research and Development Activities Regarding Cell Line Development Market
    • 5.1.2 Higher Prevalence of Cancer Cases
  • 5.2 Market Restraints
    • 5.2.1 Several Issues Related to Cell Line Development Market
  • 5.3 Market Opportunity
    • 5.3.1 Rising Advancements in the Stem Cell Research
  • 5.4 Future Trend
    • 5.4.1 Increasing Technological Advancements Concerning Cell Line Development
  • 5.5 Impact Analysis

6. Cell Line Development Market - Middle East and Africa Analysis

  • 6.1 Middle East and Africa Cell Line Development Market Revenue Forecasts and Analysis

7. Middle East and Africa Cell Line Development Market Analysis and Forecasts To 2027 - ByType

  • 7.1 Overview
  • 7.2 Cell Line Development Market, by Type, 2019& 2027 (% Share)
  • 7.3 Primary Cell Line
    • 7.3.1 Overview
    • 7.3.2 Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.4 Hybridomas
    • 7.4.1 Overview
    • 7.4.2 Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.5 Continuous Cell Lines
    • 7.5.1 Overview
    • 7.5.2 Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.6 Recombinant Cell Line
    • 7.6.1 Overview
    • 7.6.2 Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)

8. Middle East and Africa Cell Line Development Market Analysis and Forecasts To 2027 - ByProduct

  • 8.1 Overview
  • 8.2 Cell Line Development Market, by Product, 2019& 2027 (% Share)
  • 8.3 Equipment
    • 8.3.1 Overview
    • 8.3.2 Equipment Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.4 Media and Reagent
    • 8.4.1 Overview
    • 8.4.2 Media and Reagent Market Revenue and Forecast to 2027 (US$ Mn)

9. Middle East and Africa Cell Line Development Market Analysis - ByApplication

  • 9.1 Overview
  • 9.2 Cell Line Development Market Share by Application 2019& 2027 (%)
  • 9.3 Drug Discovery
    • 9.3.1 Overview
    • 9.3.2 Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.4 Bioproduction
    • 9.4.1 Overview
    • 9.4.2 Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.5 Tissue Engineering
    • 9.5.1 Overview
    • 9.5.2 Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)

10. Cell Line Development Market Revenue and Forecasts To 2027 - Geographical Analysis

  • 10.1 Middle East and Africa Cell Line Development Market, Revenue and Forecast to 2027
    • 10.1.1 Overview
    • 10.1.2 Middle East and Africa Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
    • 10.1.3 Middle East and Africa Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
    • 10.1.4 Middle East and Africa Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
    • 10.1.5 Middle East and Africa Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.1.6 Middle East and Africa Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
    • 10.1.7 UAE
      • 10.1.7.1 UAE Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.1.7.2 UAE Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.1.7.3 UAE Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.1.7.4 UAE Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.1.8 Saudi Arabia
      • 10.1.8.1 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.1.8.2 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.1.8.3 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.1.8.4 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.1.9 South Africa
      • 10.1.9.1 South Africa Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.1.9.2 South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.1.9.3 South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.1.9.4 South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)

11. Impact of COVID-19 Pandemic on Middle East and Africa Cell Line Development Market

  • 11.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12. COMPANY PROFILES

  • 12.1 Merck KGaA
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Financial Overview
    • 12.1.4 Product Portfolio
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 WuXi AppTec
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Financial Overview
    • 12.2.4 Service Portfolio
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 General Electric
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Financial Overview
    • 12.3.4 Product Portfolio
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Lonza
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Financial Information
    • 12.4.4 Product Portfolio
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of terms

List Of Tables

  • Table 1. Middle East and Africa Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 2. Middle East and Africa Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 3. Middle East and Africa Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 4. UAE Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 5. UAE Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 6. UAE Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 7. Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 8. Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 9. Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 10. South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 11. South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 12. South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 13. Glossary of Terms, Cell Line Development Market

List Of Figures

  • Figure 1. Cell Line Development Market Segmentation
  • Figure 2. Middle East and Africa Cell Line Development Market Overview
  • Figure 3. Media and Reagent Segment Held Largest Share of Product in Cell Line Development Market
  • Figure 4. Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 5. Cell Line Development Market - Middle East and Africa PEST Analysis
  • Figure 6. Cell Line Development Market Impact Analysis of Driver and Restraints
  • Figure 7. Middle East and Africa Cell Line Development Market - Revenue Forecasts and Analysis - 2019- 2027
  • Figure 8. Cell Line Development Market, Type, 2019& 2027 (% Share)
  • Figure 9. Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 10. Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 11. Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 12. Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 13. Cell Line Development Market, By Product, 2019& 2027 (% Share)
  • Figure 14. Equipment Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 15. Media and Reagent Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 16. Cell Line Development Market Share by Application 2019& 2027 (%)
  • Figure 17. Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 18. Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 19. Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 20. Middle East and Africa Cell Line Development Market, Revenue Overview, By Country, 2019 (US$ Mn)
  • Figure 21. Middle East and Africa Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 22. Middle East and Africa Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
  • Figure 23. UAE Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 24. Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 25. South Africa Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 26. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets